Gayatri BioOrganics Limited (BOM:524564)
India
· Delayed Price · Currency is INR 18.32
+0.76 (4.33%)
At close: Apr 28, 2026
Gayatri BioOrganics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | - | - | - | 16.67 | - | - | Upgrade
|
| Revenue | - | - | - | 16.67 | - | - | Upgrade
|
| Cost of Revenue | 0.01 | 0.01 | 0.03 | 16.21 | 0.04 | 0.03 | Upgrade
|
| Gross Profit | -0.01 | -0.01 | -0.03 | 0.46 | -0.04 | -0.03 | Upgrade
|
| Selling, General & Admin | 1.12 | 0.85 | 0.99 | 1.48 | 2.97 | 2.85 | Upgrade
|
| Other Operating Expenses | 4.18 | 3.63 | 4.31 | 6.67 | 1.95 | 2.09 | Upgrade
|
| Operating Expenses | 5.3 | 4.48 | 5.3 | 8.14 | 4.92 | 4.93 | Upgrade
|
| Operating Income | -5.32 | -4.5 | -5.32 | -7.68 | -4.96 | -4.96 | Upgrade
|
| Interest Expense | -3.34 | -2.77 | -1.49 | -0.28 | -0 | -0 | Upgrade
|
| Interest & Investment Income | - | - | 0 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | - | -0.01 | Upgrade
|
| EBT Excluding Unusual Items | -8.66 | -7.27 | -6.81 | -7.96 | -4.96 | -4.97 | Upgrade
|
| Pretax Income | -8.66 | -7.27 | -6.81 | -7.96 | -4.96 | -4.97 | Upgrade
|
| Income Tax Expense | - | - | - | 2.15 | - | - | Upgrade
|
| Earnings From Continuing Operations | -8.66 | -7.27 | -6.81 | -10.11 | -4.96 | -4.97 | Upgrade
|
| Net Income | -8.66 | -7.27 | -6.81 | -10.11 | -4.96 | -4.97 | Upgrade
|
| Net Income to Common | -8.66 | -7.27 | -6.81 | -10.11 | -4.96 | -4.97 | Upgrade
|
| Shares Outstanding (Basic) | 77 | 79 | 79 | 79 | 79 | 79 | Upgrade
|
| Shares Outstanding (Diluted) | 77 | 79 | 79 | 79 | 79 | 79 | Upgrade
|
| Shares Change (YoY) | -5.16% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | -0.11 | -0.09 | -0.09 | -0.13 | -0.06 | -0.06 | Upgrade
|
| EPS (Diluted) | -0.11 | -0.09 | -0.09 | -0.13 | -0.06 | -0.06 | Upgrade
|
| Free Cash Flow | - | -5.51 | -6.94 | -5.64 | -4.04 | -5.17 | Upgrade
|
| Free Cash Flow Per Share | - | -0.07 | -0.09 | -0.07 | -0.05 | -0.07 | Upgrade
|
| Gross Margin | - | - | - | 2.78% | - | - | Upgrade
|
| Operating Margin | - | - | - | -46.07% | - | - | Upgrade
|
| Profit Margin | - | - | - | -60.60% | - | - | Upgrade
|
| Free Cash Flow Margin | - | - | - | -33.80% | - | - | Upgrade
|
| EBIT | -5.32 | -4.5 | -5.32 | -7.68 | -4.96 | -4.96 | Upgrade
|
| EBIT Margin | - | - | - | -46.07% | - | - | Upgrade
|
| Revenue as Reported | - | - | - | 16.67 | - | - | Upgrade
|
| Advertising Expenses | - | - | 0.05 | 0.11 | 0.06 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.